{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:49:53Z","timestamp":1790214593039,"version":"4.1.0"},"reference-count":92,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thyroid hormones control lipid metabolism by exhibiting specific effects on the liver and adipose tissue in a coordinated manner. Different diseases of the thyroid gland can result in hypothyroidism. Hypothyroidism is frequently associated with dyslipidemia. Hypothyroidism-associated dyslipidemia subsequently results in intrahepatic accumulation of fat, leading to nonalcoholic fatty liver disease (NAFLD), which leads to the development of hepatic insulin resistance. The prevalence of NAFLD in the western world is increasing, and evidence of its association with hypothyroidism is accumulating. Since hypothyroidism has been identified as a modifiable risk factor of NAFLD and recent data provides evidence that selective thyroid hormone receptor \u03b2 (THR-\u03b2) agonists are effective in the treatment of dyslipidemia and NAFLD, interest in potential therapeutic options for NAFLD targeting these receptors is growing. In this review, we summarize current knowledge regarding clinical and molecular data exploring the association of hypothyroidism, dyslipidemia and NAFLD.<\/jats:p>","DOI":"10.3390\/ijms222312797","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:28Z","timestamp":1638314548000},"page":"12797","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD"],"prefix":"10.3390","volume":"22","author":[{"given":"Maria","family":"Mavromati","sequence":"first","affiliation":[{"name":"Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals, 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9425-3137","authenticated-orcid":false,"given":"Fran\u00e7ois R.","family":"Jornayvaz","sequence":"additional","affiliation":[{"name":"Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals, 1211 Geneva, Switzerland"},{"name":"Diabetes Center of the Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tanase, D.M., Gosav, E.M., Neculae, E., Costea, C.F., Ciocoiu, M., Hurjui, L.L., Tarniceriu, C.C., and Floria, M. (2020). Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165927"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.3748\/wjg.v19.i45.8238","article-title":"Cross-talk between the thyroid and liver: A new target for nonalcoholic fatty liver disease treatment","volume":"19","author":"Huang","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8529(05)70294-2","article-title":"Mechanisms of thyroid hormone action. Implications for the clinical manifestation of thyrotoxicosis","volume":"27","author":"Motomura","year":"1998","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1096\/fj.08-108464","article-title":"Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit\/reverse nonalcoholic fatty liver in rats","volume":"22","author":"Perra","year":"2008","journal-title":"FASEB J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.22572","article-title":"Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist","volume":"49","author":"Cable","year":"2009","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5753039","DOI":"10.1155\/2017\/5753039","article-title":"Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients","volume":"2017","author":"Liu","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1210\/jc.2018-00475","article-title":"Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD","volume":"103","author":"Bruinstroop","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1172\/JCI60580","article-title":"Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy","volume":"122","author":"Sinha","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_10","first-page":"1257","article-title":"Patterns of liver gene expression governed by TRbeta","volume":"16","author":"Gullberg","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/en.2011-1793","article-title":"Thyroid hormone receptor-alpha gene knockout mice are protected from diet-induced hepatic insulin resistance","volume":"153","author":"Jornayvaz","year":"2012","journal-title":"Endocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1210\/jc.2002-020174","article-title":"Elevated regional lipolysis in hyperthyroidism","volume":"87","author":"Riis","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jcem.86.11.7981","article-title":"Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients","volume":"86","author":"Cachefo","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1210\/en.2009-0297","article-title":"Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo","volume":"150","author":"Klieverik","year":"2009","journal-title":"Endocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1196\/annals.1296.067","article-title":"Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: An in vivo microdialysis study","volume":"1018","author":"Nedvidkova","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"D\u2019Ambrosio, R., Campi, I., Maggioni, M., Perbellini, R., Giammona, E., Stucchi, R., Borghi, M., Degasperi, E., De Silvestri, A., and Persani, L. (2021). The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249614"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19554","DOI":"10.1074\/jbc.M111771200","article-title":"Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes","volume":"277","author":"Yin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biochi.2004.11.008","article-title":"Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): Two key regulators of glucose metabolism and lipid synthesis in liver","volume":"87","author":"Dentin","year":"2005","journal-title":"Biochimie"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1530\/EC-20-0490","article-title":"Pathophysiology of NASH in endocrine diseases","volume":"10","author":"Gariani","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.31296","article-title":"Thyroid Hormone Signaling and the Liver","volume":"72","author":"Ritter","year":"2020","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mce.2017.02.015","article-title":"Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2","volume":"446","author":"Li","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1210\/jc.2009-0212","article-title":"Thyroid hormone-related regulation of gene expression in human fatty liver","volume":"94","author":"Pihlajamaki","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1073\/pnas.0508556102","article-title":"Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action","volume":"102","author":"Araki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2010.07.006","article-title":"Autophagy in liver diseases","volume":"53","author":"Rautou","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.etp.2009.04.009","article-title":"Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats","volume":"62","author":"Messarah","year":"2010","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nrgastro.2009.33","article-title":"Endocrine and liver interaction: The role of endocrine pathways in NASH","volume":"6","author":"Loria","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07435800009040142","article-title":"The regulatory effects of thyroid hormone on the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"26","author":"Choi","year":"2000","journal-title":"Endocr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.gastro.2008.01.032","article-title":"Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone","volume":"134","author":"Galman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_31","first-page":"513","article-title":"High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment","volume":"59","author":"Lam","year":"1986","journal-title":"Q. J. Med."},{"key":"ref_32","first-page":"140","article-title":"Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism","volume":"83","author":"Tan","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jc.2011-2532","article-title":"Update in lipid alterations in subclinical hypothyroidism","volume":"97","author":"Pearce","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/thy.2000.10.981","article-title":"Low-density lipoprotein cholesterol in subclinical hypothyroidism","volume":"10","author":"Vierhapper","year":"2000","journal-title":"Thyroid"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1370\/afm.79","article-title":"Subclinical hypothyroidism and the risk of hypercholesterolemia","volume":"2","author":"Hueston","year":"2004","journal-title":"Ann. Fam. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archinte.162.7.773","article-title":"Association between thyroid dysfunction and total cholesterol level in an older biracial population: The health, aging and body composition study","volume":"162","author":"Kanaya","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of Nonalcoholic Steatohepatitis: An Overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Asrih, M., Altirriba, J., Rohner-Jeanrenaud, F., and Jornayvaz, F.R. (2015). Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126364"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/JOE-15-0136","article-title":"Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21","volume":"226","author":"Camporez","year":"2015","journal-title":"J. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.M054080","article-title":"ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content","volume":"56","author":"Camporez","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","article-title":"The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet","volume":"227","author":"Somm","year":"2021","journal-title":"Transl. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1038\/s41598-019-53346-4","article-title":"Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism","volume":"9","author":"Montandon","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/er.2018-00134","article-title":"Fibroblast Growth Factor 15\/19: From Basic Functions to Therapeutic Perspectives","volume":"39","author":"Somm","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e91809","DOI":"10.1172\/jci.insight.91809","article-title":"beta-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue","volume":"2","author":"Somm","year":"2017","journal-title":"JCI Insight"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin resistance in nonalcoholic fatty liver disease","volume":"16","author":"Bugianesi","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.012809.104726","article-title":"The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome","volume":"30","author":"Jornayvaz","year":"2010","journal-title":"Annu. Rev. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ecl.2004.03.016","article-title":"Metabolic abnormalities: Triglyceride and low-density lipoprotein","volume":"33","author":"Krauss","year":"2004","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11053","DOI":"10.3748\/wjg.v21.i39.11053","article-title":"Endocrine causes of nonalcoholic fatty liver disease","volume":"21","author":"Marino","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00004836-200310000-00014","article-title":"Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?","volume":"37","author":"Liangpunsakul","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cgh.2006.07.011","article-title":"Hypothyroidism: A possible risk factor for liver cancer in patients with no known underlying cause of liver disease","volume":"5","author":"Reddy","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1478-3231.2009.02003.x","article-title":"Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease","volume":"29","author":"Silveira","year":"2009","journal-title":"Liver Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2265.2011.04016.x","article-title":"Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese","volume":"75","author":"Xu","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jhep.2012.05.025","article-title":"Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: A prospective case-control study","volume":"57","author":"Xu","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/thy.2011.0279","article-title":"Inverse association between serum free thyroxine levels and hepatic steatosis: Results from the Study of Health in Pomerania","volume":"22","author":"Ittermann","year":"2012","journal-title":"Thyroid"},{"key":"ref_63","first-page":"584","article-title":"Nonalcoholic fatty liver disease in a cluster of Iranian population: Thyroid status and metabolic risk factors","volume":"16","author":"Eshraghian","year":"2013","journal-title":"Arch. Iran. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1530\/EJE-14-0150","article-title":"Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis","volume":"171","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3350\/cmh.2015.21.4.372","article-title":"Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12664-015-0541-z","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease in patients attending a tertiary hospital in western India","volume":"34","author":"Parikh","year":"2015","journal-title":"Indian J. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Ludwig, U., Holzner, D., Denzer, C., Greinert, A., Haenle, M.M., Oeztuerk, S., Koenig, W., Boehm, B.O., Mason, R.A., and Kratzer, W. (2015). Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: A cross-sectional study of a random population sample aged 18 to 65 years. BMC Endocr. Disord., 15.","DOI":"10.1186\/s12902-015-0030-5"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study","volume":"101","author":"Bano","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2017.08.014","article-title":"Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_70","first-page":"1","article-title":"Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population","volume":"154","author":"Pera","year":"2020","journal-title":"Med. Clin."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: A systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Loosen, S.H., Demir, M., Kostev, K., Luedde, T., and Roderburg, C. (2021). Incidences of hypothyroidism and autoimmune thyroiditis are increased in patients with nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol.","DOI":"10.1097\/MEG.0000000000002136"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000454920","article-title":"Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis","volume":"6","author":"Jaruvongvanich","year":"2017","journal-title":"Eur. Thyroid J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1089\/thy.2018.0257","article-title":"Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"28","author":"Mantovani","year":"2018","journal-title":"Thyroid"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fendo.2017.00335","article-title":"Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"8","author":"He","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.cgh.2018.11.024","article-title":"Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States","volume":"17","author":"Kim","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000654","article-title":"Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality","volume":"115","author":"Kim","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.14218\/JCTH.2020.00027","article-title":"Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications","volume":"8","author":"Kizivat","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/bj2730375","article-title":"Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats","volume":"273","author":"Redgrave","year":"1991","journal-title":"Biochem. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1080\/03007995.2017.1330259","article-title":"Thyroid hormone analogs for the treatment of dyslipidemia: Past, present, and future","volume":"33","author":"Delitala","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"15358","DOI":"10.1073\/pnas.2136689100","article-title":"Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor","volume":"100","author":"Borngraeber","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1210\/endo.141.9.7681","article-title":"The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity","volume":"141","author":"Trost","year":"2000","journal-title":"Endocrinology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/en.2010-0813","article-title":"In vivo activity of the thyroid hormone receptor beta- and alpha-selective agonists GC-24 and CO23 on rat liver, heart, and brain","volume":"152","author":"Samarut","year":"2011","journal-title":"Endocrinology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-8587(14)70006-3","article-title":"Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): A randomised, double-blind, placebo-controlled phase 3 study","volume":"2","author":"Sjouke","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"362","author":"Ladenson","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12261","article-title":"Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome","volume":"277","author":"Angelin","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2013.07.056","article-title":"Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-beta agonist","volume":"230","author":"Taub","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21037\/tgh.2019.06.06","article-title":"Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis","volume":"4","author":"Wong","year":"2019","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1124\/dmd.108.021642","article-title":"Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist","volume":"36","author":"Fujitaki","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1073\/pnas.0702759104","article-title":"Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index","volume":"104","author":"Erion","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12797\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:30Z","timestamp":1760168190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":92,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222312797"],"URL":"https:\/\/doi.org\/10.3390\/ijms222312797","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}